secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2024-04-10T23:59:59+00:00
Accession:  0001558370-24-004933
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences gets Nasdaq bid-price extension until Oct 7, 2024; may reverse split
--------------------------------------------------------------------------------

- Received Nasdaq Staff notice on April 9, 2024, that minimum $1.00 bid price still not met.
- Granted additional 180-day compliance period; deadline now October 7, 2024.
- If closing bid price ≥ $1.00 for 10 consecutive business days, compliance confirmed.
- Failure by Oct 6, 2024 triggers delisting notice; company may appeal to Hearings Panel.
- Stockholders approved reverse stock split ratio between 1:10 and 1:60 to remedy deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000155837024004933/0001558370-24-004933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000155837024004933/rsls-20240409x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-004933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer